Microbiome Diagnostics Partners' Corporate Minority - II Round

Microbiome Diagnostics Partners raised a round of funding on July 11, 2017. Investors include Enterome.

Microbiome Diagnostics Partners (MDP) develops microbiome-based diagnostics for inflammatory bowel and liver diseases, like non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. MDP was…

Articles about Microbiome Diagnostics Partners' Corporate Minority - II Round: